Bruker Corporation
BRKR
Ранг среди акций
#2368
Bruker Corporation stands as a prominent global developer, manufacturer, and... Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
Цена акции
$54.54
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$8.31B
Изменение (1 день)
-3.55%
Изменение (1 год)
47.47%
Страна
US
Торговля Bruker Corporation (BRKR)
Категория
Healthcare
Операционная маржа для Bruker Corporation (BRKR)
Операционная маржа на October 2026 TTM: 3.61%
Согласно последним финансовым отчетам и цене акций Bruker Corporation, текущая операционная маржа (TTM) составляет 3.61%. В конце 2023 она составила 14.74%.
История операционной маржи Bruker Corporation с 2000 по 2026
Операционная маржа на конец каждого года
| Год | Операционная маржа | Изменить |
|---|---|---|
| 2026 (TTM) | 3.61% | -51.99% |
| 2024 | 7.52% | -48.98% |
| 2023 | 14.74% | -13.80% |
| 2022 | 17.10% | 0.06% |
| 2021 | 17.09% | 36.83% |
| 2020 | 12.49% | -13.98% |
| 2019 | 14.52% | 4.91% |
| 2018 | 13.84% | 13.82% |
| 2017 | 12.16% | 10.55% |
| 2016 | 11.00% | 22.63% |
| 2015 | 8.97% | 53.86% |
| 2014 | 5.83% | -27.67% |
| 2013 | 8.06% | -7.46% |
| 2012 | 8.71% | -7.54% |
| 2011 | 9.42% | -21.04% |
| 2010 | 11.93% | -2.77% |
| 2009 | 12.27% | 25.59% |
| 2008 | 9.77% | 7.01% |
| 2007 | 9.13% | 29.69% |
| 2006 | 7.04% | 97.20% |
| 2005 | 3.57% | -1,015.38% |
| 2004 | -0.39% | -89.49% |
| 2003 | -3.71% | -175.10% |
| 2002 | 4.94% | 39.94% |
| 2001 | 3.53% | 267.71% |
| 2000 | 0.96% | 0.00% |
Операционная маржа для аналогичных компаний или конкурентов
| Компания | Операционная маржа | Разница в операционной марже | Страна |
|---|---|---|---|
| 17.03% | -95.28% |
US
|
|
| 17.86% | -95.05% |
IE
|
|
| 22.03% | -93.90% |
US
|
|
| 21.46% | -94.06% |
US
|
|
| 0.00% | - |
DE
|
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.